Canada· CA-DIN-02231962
CYTOGAM
A cytomegalovirus immunoglobulin product containing cytomegalovirus immunoglobulin (human), registered in Canada by KI BIOPHARMA LLC. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Cytomegalovirus immunoglobulin is registered in 9 of 19 countries.
Countries holding a registration under ATC J06BB09 (cytomegalovirus immunoglobulin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Cytomegalovirus immunoglobulin · ATC J06BB09
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CYTOMEGALOVIRUS IMMUNOGLOBULIN (HUMAN)
- Manufacturer
- KI BIOPHARMA LLC
- Country
- Canada (CA)
- ATC code
- J06BB09
- ATC class
- Cytomegalovirus immunoglobulin
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cytomegalovirus immunoglobulin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIvegam-CMV 100 mg/mlCentrale Afdeling Voor Fractionering - Departement Central De Fractionnement
- United KingdomCytomegalovirus immunoglobulin human 3g powder for solution for infusion vialsScottish National Blood Transfusion Service
- SpainMEGALOTECT 100 U/ML SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- GermanyCytotect CpBiotest Pharma Gmbh
- IrelandMegalotect 100 U/mL solution for infusionBiotest Pharma GmbH
- NetherlandsMegalotect 100 E/ml oplossing voor infusieBiotest Pharma GmbH
- PolandMegalotect CPBiotest Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Cytotect Cp
- Belgium · Megalotect
- Czechia · Cymvigo
- Germany · Cytotect Cp
- Spain · Megalotect
- United Kingdom (Northern Ireland) · Cytotect Cp
- Greece · Megalotect Cp
- Croatia · Cytotect Cp
- Hungary · Cytotect Cp
- Ireland · Megalotect
- Italy · Cytomegatect
- Lithuania · Cymvigo
- Netherlands · Megalotect
- Poland · Megalotect Cp
- Portugal · Megalotect Cp
- Romania · Cytotect Cp
- Slovenia · Megalotect
- Slovakia · Cytotect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/60c51d99-b417-4e65-82a6-ea040896660f GET /v1/drugs/60c51d99-b417-4e65-82a6-ea040896660f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02231962",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J06BB09",
"schedule": [
"Schedule D"
],
"drug_code": "51418",
"strengths": [
"2500 MG"
],
"ahfs_class": null,
"substances": [
"CYTOMEGALOVIRUS IMMUNOGLOBULIN (HUMAN)"
],
"product_categorization": null
}See everything about cytomegalovirus immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.